Lindal expands relationship with Russia's Nativa in drug-delivery technology


Nativa, the Russian pharmaceutical company founded in 2010, recently announced a strategic agreement concerning cooperation in the manufacture of dispensing systems for respiratory disease treatment with Vari, a wholly-owned subsidiary of Lindal Group and one of the leading makers of valves and actuators for pharmaceutical aerosol systems.

Such cooperation includes metered dose inhalers, which require the highest levels of technical and manufacturing expertise. These solutions use carefully engineered valves made to handle active ingredients and optimize delivery of low doses of medication directly inside the bronchial tree.

Both Vari and Nativa anticipate further growth of their business relationship. "Lindal is pleased to have this opportunity to broaden its relationship with Nativa," said Phil Lever, Group Sales Director for the pharmaceutical company.

Read more